Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Neu

Showing results (51-60 of 505) with videos related to

Pageof 51
Sort By:
Hospital Practice (Office Ed.)|November 30, 1985
CNS infection. First things firstH C Neu
Antimicrobial Agents and Chemotherapy|May 1, 1976
Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteriaH C Neu
The American Journal of Medicine|November 30, 1989
New oral and parenteral quinolones. A summaryH C Neu
Infection|January 1, 1980
Optimal antibiotic therapy in bronchopulmonary infectionsH C Neu
Reviews of Infectious Diseases|January 1, 1981
The pharmacokinetics of bacampicillinH C Neu
The Journal of Antimicrobial Chemotherapy|November 1, 1982
Factors that affect the in-vitro activity of cephalosporin antibioticsH C Neu
Science (New York, N.Y.)|August 21, 1992
The crisis in antibiotic resistanceH C Neu
Reviews of Infectious Diseases|May 1, 1987
Controversies in the diagnosis and management of infectious diseases: conclusionsH C Neu
The New England Journal of Medicine|April 27, 1989
Case 43-1988H C Neu
Diagnostic Microbiology and Infectious Disease|July 1, 1989
Overview of mechanisms of bacterial resistanceH C Neu
Pageof 51

Showing results (51-60 of 505) with videos related to

Sort By:
Pageof 51
Hospital Practice (Office Ed.)|November 30, 1985
CNS infection. First things firstH C Neu
Antimicrobial Agents and Chemotherapy|May 1, 1976
Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteriaH C Neu
The American Journal of Medicine|November 30, 1989
New oral and parenteral quinolones. A summaryH C Neu
Infection|January 1, 1980
Optimal antibiotic therapy in bronchopulmonary infectionsH C Neu
Reviews of Infectious Diseases|January 1, 1981
The pharmacokinetics of bacampicillinH C Neu
The Journal of Antimicrobial Chemotherapy|November 1, 1982
Factors that affect the in-vitro activity of cephalosporin antibioticsH C Neu
Science (New York, N.Y.)|August 21, 1992
The crisis in antibiotic resistanceH C Neu
Reviews of Infectious Diseases|May 1, 1987
Controversies in the diagnosis and management of infectious diseases: conclusionsH C Neu
The New England Journal of Medicine|April 27, 1989
Case 43-1988H C Neu
Diagnostic Microbiology and Infectious Disease|July 1, 1989
Overview of mechanisms of bacterial resistanceH C Neu
Pageof 51